Using protein microarray technology to screen anti-ERCC1 monoclonal antibodies for specificity and applications in pathology (Q34484477)

2 August 2017

title

Using protein microarray technology to screen anti-ERCC1 monoclonal antibodies for specificity and applications in pathology (English)

1 reference

2 August 2017

0 references

1 reference

1 reference

Donghui Ma

1

1 reference

2 August 2017

Dror Baruch

2

1 reference

2 August 2017

Youmin Shu

3

1 reference

2 August 2017

Kehu Yuan

4

1 reference

2 August 2017

Zairen Sun

5

1 reference

2 August 2017

Kaiyan Ma

6

1 reference

2 August 2017

Toan Hoang

7

1 reference

2 August 2017

Wei Fu

8

1 reference

2 August 2017

Li Min

9

1 reference

2 August 2017

Zhu-Sheng Lan

10

1 reference

2 August 2017

Fangxun Wang

11

1 reference

2 August 2017

Lori Mull

12

1 reference

2 August 2017

Wei-Wu He

13

1 reference

2 August 2017

publication date

21 November 2012

1 reference

2 August 2017

1 reference

2 August 2017

volume

12

1 reference

2 August 2017

page(s)

88

1 reference

Creative Commons Attribution 2.0 Generic

2 August 2017

copyright license

start time

21 November 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Comparative nephrotoxicity of Cisplatin and nedaplatin: mechanisms and histopathological characteristics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3526464

Pre-treatment tumor expression of ERCC1 in women with advanced stage epithelial ovarian cancer is not predictive of clinical outcomes: a Gynecologic Oncology Group study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3526464

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3526464

Mechanisms of Cisplatin nephrotoxicity

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3526464

Role of adjuvant chemotherapy in NSCLC (stages I to III).

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3526464

Automated ERCC1 immunochemistry on hybrid cytology/tissue microarray of malignant effusions: evaluation of antibodies 8F1 and D-10

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3526464

Molecular Characteristics of ERCC1-Negative versus ERCC1-Positive Tumors in Resected NSCLC.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3526464

Prognostic role of ERCC1 in advanced non-small-cell lung cancer: a systematic review and meta-analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3526464

Multiple roles of the ERCC1-XPF endonuclease in DNA repair and resistance to anticancer drugs

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3526464

Adjuvant cisplatin-based chemotherapy for resected NSCLC: one size fits all?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3526464

Multiple roles of ERCC1-XPF in mammalian interstrand crosslink repair

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3526464

14-3-3zeta escorts CCTalpha for calcium-activated nuclear import in lung epithelia.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3526464

Immunodetection of DNA repair endonuclease ERCC1-XPF in human tissue.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3526464

Class III beta-tubulin, but not ERCC1, is a strong predictive and prognostic marker in locally advanced head and neck squamous cell carcinoma.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3526464

Tissue profiling of the mammalian central nervous system using human antibody-based proteomics

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3526464

Human protein factory for converting the transcriptome into an in vitro-expressed proteome,.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3526464

Platinum resistance: the role of DNA repair pathways

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3526464

Transcriptional regulation of phosphatidylcholine biosynthesis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3526464

Cisplatin nephrotoxicity: mechanisms and renoprotective strategies

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3526464

Cisplatin nephrotoxicity: molecular mechanisms.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3526464

Antibody screening database for protein kinetic modeling

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3526464

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3526464

Cellular processing of platinum anticancer drugs

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3526464

Antibody-based proteomics for human tissue profiling

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3526464

Excision repair cross complementing-group 1: gene expression and platinum resistance.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3526464

DNA repair and cisplatin resistance in non-small-cell lung cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3526464

CTP:phosphocholine cytidylyltransferase alpha is a cytosolic protein in pulmonary epithelial cells and tissues

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3526464

Increased nucleotide excision repair in cisplatin-resistant ovarian cancer cells: role of ERCC1-XPF.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3526464

Hybrid hybridomas producing bispecific antibodies to CEA and peroxidase isolated by a combination of HAT medium selection and fluorescence activated cell sorting.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3526464

DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer.

6 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6750-12-88

Automated ERCC1 immunohistochemistry in non-small cell lung cancer: comparison of anti-ERCC1 antibodies 8F1, D-10, and FL-297.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6750-12-88

DNA repair gene excision repair cross complementing-group 1 (ERCC1) in head and neck squamous cell carcinoma: analysis of methylation and polymorphism (G19007A), protein expression and association with epidemiological and clinicopathological factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6750-12-88

Patients with ERCC1-negative locally advanced esophageal cancers may benefit from preoperative chemoradiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6750-12-88

Low ERCC1 mRNA and protein expression are associated with worse survival in cervical cancer patients treated with radiation alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6750-12-88

Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small cell lung cancer.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3526464

Hybrid hybridomas and their use in immunohistochemistry

27 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6750-12-88

Twenty-two years of phase III trials for patients with advanced non-small-cell lung cancer: sobering results

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23171216

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

ERCC1 and non-small-cell lung cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23171216

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1472-6750-12-88

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference

2 August 2017

1 reference